 |
|
|
 Hot Stock to Watch
|
Company: Artemis Energy Holdings, Inc. (Pink Sheets: ARTT)
|
Last:
Price: 0.04
Change (%): + 0.005 (14.29)
Volume: 6,000 |
 |
Artemis Energy Holdings Enters Into Definitive Agreement to Acquire WooEB.com
ATLANTA, GA--(Marketwired - Sep 11, 2013) - Artemis Energy Holdings, Inc. (OTC Pink: ARTT) announced today that it has entered into a definitive agreement to acquire WooEB.com. WooEB.com is an online social networking portal that provides members the ability to manage their online content. WooEB.com currently is ranked according to Alexa Global Rank 45,935. The agreement calls for the acquisition of the assets of WooEB,Inc. which is www.WooEB.com and its technology, along with its members.
Tom Powers of Artemis Energy Holdings stated "With the addition of WooEB.com and the revenue streams it provides I think this acquisition will enhance the overall portfolio of Artemis Energy Holdings for our shareholders."
Continue Reading |
Other Small Cap News
|
Company: Nuvilex, Inc. (OTCQB: NVLX)
|
Nuvilex Forms Key Alliance With Industry Leader
BALTIMORE, MD--(Marketwired - Sep 12, 2013) - In a newly released article, Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, notes that earlier this week, Nuvilex, Inc. (OTCQB: NVLX) announced it had entered into a contract with Fisher BioServices, Inc., a part of medical services giant Thermo Fisher Scientific, Inc. for the long-term storage of cells that will be required for future Phase III clinical trials in pancreatic cancer and for studies in other cancers. This is a huge deal for Nuvilex and demonstrates how far along the Company is in clinical trial development, which should act as a catalyst to move the stock's valuation significantly higher.
Continue Reading
|
Company: CodeSmart Holdings, Inc. (OTCQB: ITEN)
|
Codesmart(TM) Group Partners with LearnScale(TM) to Provide Enrollment Services for CODESMART(TM) UNIVERSITY Students
NEW YORK, Sept. 12, 2013 (GLOBE NEWSWIRE) -- CodeSmart Holdings, Inc. (OTCQB:ITEN), with its subsidiary, The CODESMARTTM Group, Inc. (collectively, "CODESMART"), a premier ICD-10 education and solutions group that offers CODESMARTTM UNIVERSITY, its on-line education solution and customizable training solutions, announces today that it has partnered with The Learning Corporation, Inc., doing business as LearnScaleTM, to provide enrollment services and financing options for students interested in CODESMARTTM UNIVERSITY'S ICD-10 certification programs.
his partnership is very important as it represents our first foray into reaching out directly to individual students to offer our CODESMARTTM UNIVERSITY programs," said Ira Shapiro, Chairman and CEO of CODESMARTTM. "We have chosen LearnScale to provide enrollment and call center services to potential students and offer convenient payment options. LearnScale will be instrumental in assisting potential new coders to fill the hundreds of thousands of new jobs that will become available as a result of the switch to ICD-10 next year."
Continue Reading |
Market News
|
By JeeYeon Park: CNBC.com Stock Market Writer
|
Stocks close near highs, S&P 500 logs 7-day rally; Apple slumps 5%
The Dow and S&P 500 finished near session highs Wednesday, with the S&P logging its seventh-consecutive session in positive territory. But the Nasdaq ended lower, dragged by Apple's sharp decline.
The Dow Jones Industrial Average soared 135.54 points to finish at 153,26.60, logging a three-day win streak, boosted by IBM and Disney.
The S&P 500 climbed 5.14 points to close at 1,689.13. But the Nasdaq slid 4.01 points to end at 3,725.01. So far this month, all three major averages are up more than 3 percent each.
Continue Reading
|
By Lee Brodie: CNBC
|
Cramer: Take profits in this drug stock
Sometimes a spec stock turns out to be more right than even Cramer imagined.
That's certainly the case with NPS Pharma (NPSP), an orphan drug maker, whose stock has exploded.
When Cramer talked with the CEO on Mad Money early in the year he noted the potential. At the time said the stock seemed cheap in light of the promising pipeline. "I think we may be looking a real opportunity," he said on January 7th .
How right Cramer was.
As it turned out, "NPS had some incredible success with its lead drug, Gattex for short-bowel syndrome, a rare condition where the intestines can't properly absorb nutrients and patients must therefore be fed through a tube, intravenously, for 12 hours a day."
Continue Reading
|
  |
IMPORTANT DISCLAIMER - PLEASE READ THOROUGHLY
SmallCapVoice (SCV) is an electronic publication. Information sources for our profiles include, but are not limited to, online research, member suggestions, magazines, newspapers, analyst suggestions, information provided by the profiled company, press releases and similar sources. This communication is not an offer to sell or a recommendation that you buy or sell any security. SCV holds no securities licenses and is not qualified to provide investment advice. We are compensated for these advertisements by the profiled companies. You should not use this newsletter as the sole basis for any investment decision. While all investments involve risk, microcap stocks are among the most risky. Many microcap companies have no proven track record. You should only invest in microcap companies if you can afford to lose your entire investment. You should consult a qualified, licensed financial advisor or stock broker before making any decisions to invest in the securities of any company that is described in these profiles. These profiles are paid advertisements. Although we have a reasonable belief that the information in each profile is accurate, we cannot guarantee that the information is accurate. It is important for you to verify all information by your own independent research. You are receiving this message because you have agreed to receive emails from SmallCapVoice.com. You may opt out of our distribution list at any time by clicking on the "unsubscribe" link below. Link to full disclosure about compensation paid to SmallCapVoice.com, Inc. by companies featured on our website or in our e-mail communications. |
About Penny Stocks |
|
|
